Answers are grounded in this paper and cite their sources.
TRITRIAL showed that the BDP/FF/G fixed combination is effective and safe in patients with moderate-severe COPD and poorly controlled disease, improving patients' HRQoL, sleep quality, adherence and inhaler usability and reducing COPD symptoms and the risk of exacerbation in a real-life setting.
No takes yet. Share an insight, caveat, or question.
Richeldi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: